Global Injectable Drug Delivery Market 2025 Survey – Global Industry Share, Size, Trends and Forecasts, by Top Players Baxter International, Inc., Becton Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG

Global Injectable Drug Delivery Market, Type (Injectable Drug Delivery Devices, Injectable Drug Delivery Formulation), Application (Hormonal Disorders, orphan disease, other applications), Usage Pattern, Mode Of Administration, End User (Hospitals And Clinics, Home Healthcare Settings, Research Laboratories, Pharmaceutical And Biotechnological Companies, Other End Users), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tender, Online Pharmacy),Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) – Industry Trends and Forecast to 2025 Global Injectable Drug Delivery Market is expected to reach USD 1,104,096.5 million by 2025 from USD 378,998.2 million in 2017, at a CAGR of 12.4% in the forecast to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast  to 2025.

Get Sample Copy of Report @

Key Points: Global Injectable Drug Delivery Market

Baxter International, Inc., Becton Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Ypsomed, and Bespak, among other players

  • Formulations are expected to dominate the global Injectable drug delivery market with the market share of 75.7%
  • Plastics in the global injectable drug delivery devices market are driving the market with a CAGR Of 11.2%

The global injectable drug delivery market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Baxter International, Inc., Becton Dickinson and Company, Gerresheimer AG, Pfizer, Inc., Schott AG, Alkermes Plc., Eli Lilly and Company, Sandoz, Terumo Corporation, Teva Pharmaceuticals Industries Ltd., Ypsomed, and Bespak, among other players

Major Topics Covered in this Report:

  • Chapter 1 Study Coverage
  • Chapter 2 Executive Summary
  • Chapter 3 Market Size by Manufacturers
  • Chapter 4 Supervisory Control and Data Acquisition System Production by Regions
  • Chapter 5 Supervisory Control and Data Acquisition System Consumption by Regions
  • Chapter 6 Market Size by Type
  • Chapter 7 Market Size by Application
  • Chapter 8 Manufacturers Profiles
  • Chapter 9 Production Forecasts
  • Chapter 10 Consumption Forecast
  • Chapter 11 Upstream, Industry Chain and Downstream Customers Analysis
  • Chapter 12 Opportunities & Challenges, Threat and Affecting Factors
  • Chapter 13 Key Findings

Chapter 14 Appendix 

For Report TOC Request Here:


Founded in 1897 as Becton, Dickinson and Company and head quartered in New Jersey, U.S. is focused on developing, manufacturing and sales of medical supplies, devices, laboratory equipment and diagnostic products. The company operates through two business segments: BD Medical and BD Life Sciences. Its medical segment business unit includes Diabetes Care, Medication and Procedural Solutions, Medication Management Solutions, and Pharmaceutical Systems. These business units’ segmentsincludeneedles and syringes, intravenous catheters, self-injection system, insulin syringes and pen needles, prefilled IV flush syringes products.

The company’s operations span across North & South America, Europe, Australia, China, India, Japan, Korea, Taiwan and South East Asia. Some of its subsidiaries include Accuri Cytometers, Inc. (Delaware), BD Holding S. de R.L. de C.V. (Mexico), Becton Dickinson AcuteCare Holdings, Inc. (Delaware), Becton Dickinson Asia Limited (Hong Kong), Becton Dickinson Austria GmbH (Austria), CareFusion Corporation (Delaware, and U.K. Medical, Ltd. (U.K.) among others


Incorporated in June 1942 and headquartered in New York, U.S. Pfizer Inc., is engaged in discovering, developing and, manufacturing of healthcare products. Pfizer Inc., operates through two segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The Company’s IH segment concentrates on creating and commercializing immunizations and prescriptions that enhance patients’ lives, and in addition products for the end user health care. Its therapeutic regions incorporate oncology, antibodies, cardiovascular, metabolic, irritation, immunology, neuroscience, torment, uncommon illnesses and purchaser human services. The Company’s EH portion incorporates legacy brands that have lost or will soon lose market superiority in both rising and developed markets, biosimilars marked generics, generic sterile injectable products and mixture frameworks. EH segment additionally incorporates another EH innovative work association, and additionally contract manufacturing business.

The company has a strong geographic presence in more than 40 countries across North America, Latin America, Europe, Eastern Europe, the Middle East, Africa, and Asia-Pacific, with manufacturing units in Europe, the Middle East and Africa, Asia-Pacific, Japan, Latin America, and the U.S. The subsidiaries of the company include Agouron Pharmaceuticals (U.S.), G.D. Searle & Company (U.S.), Innopharma (U.S.), Greenstone (U.S.), Parke-Davis (U.S.), and Pfizer (U.K.)


Founded in 1931 and headquartered in Illinois, U.S., Baxter International, Inc. manufactures medical devices, pharmaceuticals, and biotechnology products. The company operates through two business segments, namely, BioScience and Medical Products. The company provides a wide range of products for the treatment of hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Through the Medical Products segment, the company offers intravenous solutions, administration and nutrition sets, drug reconstitution systems, prefilled syringes (with and without needles) and vials, and infusion pumps and inhalation anesthetics. On the other hand, the BioScience business segment focuses on the treatment of hemophilia and other bleeding disorders by processing recombinant and plasma-based proteins.

The company has a strong geographic presence across the globe, spanning North America, Europe, the Middle East, Africa, Latin America, and Asia-Pacific. The company has three subsidiaries, namely, Gambro (U.S.), Baxter Healthcare Corporation (U.S.), and Baxter World Trade Corporation (U.S.).

To Enquire Regarding This Report @

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, South America, MEA, Europe or Asia | Mail us at
About Us:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Data Bridge Market Research
Tel: +1-888-387-2818

Show More